Mallinckrodt and Endo, pharmaceutical companies that have each encountered business struggles, announced Thursday a $6.7 billion merger that they contend will result in a combined entity with the ...

March 12 (Reuters) - Mallinckrodt and Endo (NDOI.PK), opens new tab are exploring a potential merger that could be valued at about $7 billion, person familiar with the matter told Reuters on ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...